US2022024990A1PendingUtilityA1
Species of tobamovirus
Est. expiryJul 17, 2035(~9 yrs left)· nominal 20-yr term from priority
C12Q 1/701C12N 7/00C07K 16/10C07K 14/005G01N 33/5097C12N 2770/00021C12N 2770/00022C12N 2770/00031
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides a new species of tobamovirus and its use to identify plants comprising resistance against the virus.
Claims
exact text as granted — not AI-modified1 . (canceled)
2 . (canceled)
3 . (canceled)
4 . (canceled)
5 . A sterilized solution comprising a tobamovirus whose genome comprises at least 95% sequence identity to SEQ ID NO: 1, wherein the virus causes systemic symptoms on Solanum lycopersicum plants homozygous for one or more Tm resistance genes of Tm1, Tm2, and/or Tm2 2 .
6 . (canceled)
7 . (canceled)
8 . (canceled)
9 . (canceled)
10 . (canceled)
11 . (canceled)
12 . (canceled)
13 . (canceled)
14 . (canceled)
15 . (canceled)
16 . (canceled)
17 . A protein selected from the group consisting of: a protein comprising at least 93% sequence identity to SEQ ID NO: 3, a protein comprising at least 94% sequence identity to SEQ ID NO: 4, a protein, comprising at least 80% sequence identity to SEQ ID NO: 5 and a protein, or of a nucleic acid sequence encoding a protein, comprising at least 82% sequence identity to SEQ ID NO: 6.
18 . An antibody raised against a protein or protein part selected from the group consisting of: a protein comprising at least 93% sequence identity to SEQ ID NO: 3, a protein comprising at least 94% sequence identity to SEQ ID NO: 4, a protein, comprising at least 80% sequence identity to SEQ ID NO: 5 and a protein, or of a nucleic acid sequence encoding a protein, comprising at least 82% sequence identity to SEQ ID NO: 6.
19 . The sterilized solution of claim 5 , wherein the virus causes systemic symptoms on Solanum lycopersicum plants homozygous for Tm2 2 .
20 . The sterilized solution of claim 5 , wherein the virus causes systemic symptoms on Solanum lycopersicum plants homozygous for Tm1, Tm2, and Tm2 2 .
21 . The sterilized solution of claim 5 , wherein the tobamovirus genome comprises at least 97% sequence identity to SEQ ID NO: 1.
22 . The sterilized solution of claim 5 , wherein the tobamovirus genome comprises at least 99% sequence identity to SEQ ID NO: 1.
23 . The sterilized solution of claim 5 , wherein the tobamovirus genome comprises SEQ ID NO: 1.
24 . The sterilized solution of claim 5 , wherein the sterilized solution comprises a buffer.Join the waitlist — get patent alerts
Track US2022024990A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.